328 completed, 141 unknown, 133 recruiting, 44 not yet recruiting. 317 Not applicable, 110 Phase 2, 46 Phase 3, 27 Phase 1, 11 Phase 4.
Follow Post-Infectious Disorders: new trials by email Literature Review of Post-Infectious Disorders trials Research Report on Post-Infectious Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Blood Biomarkers for Prognostic Stratification in Guillain-Barré Syndrome Blood Biomarker Panel Assessment (EGR1, EGR2, GBP1, miR-29c, and Piccolo) - Guillain Barré Syndrome | Recruiting | Anahuac University | 140 | 2027-12-01 | 2026-11-13 | |
| Taurine Supplementation in Adolescents With Post-COVID Condition Taurine - Long COVID, Post COVID-19 Condition | Phase 1 / Phase 2 | Not yet recruiting | University of Alberta | 30 | 2026-12-30 | 2026-10-16 |
| CD19-B Cell Depletion in PAIS-ME/CFS Patients Inebilizumab, Placebo - Post-acute Infectious Syndrome (PAIS), Post-COVID 19 Condition (PCC or Long COVID) | Phase 2 | Not yet recruiting | Charite University, Berlin, Germany | 38 | 2026-12-01 | 2026-07-24 |
| A Study of Empasiprubart as Add-On Therapy to IVIg in Adult Participants With Guillain-Barré Syndrome Empasiprubart IV, Empasiprubart Placebo IV, Intravenous immunoglobulin (IVIg) - Guillain-Barré Syndrome (GBS) | Phase 2 | Not yet recruiting | argenx | 63 | 2026-12-01 | 2026-10-28 |
| Effect of PNF + Core Strengthening Exercise in Sub-acute Guillain Barre Syndrome ( PNF-CORE-GBS ) Proprioceptive neuromuscular facilitation, core strengthening exercise, conventional physiotherapy - Guillain Barré Syndrome | Not applicable | Not yet recruiting | University of Lahore | 32 | 2026-11-30 | 2026-11-13 |
| Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I) Keytruda - Post-Acute COVID-19 Syndrome | Phase 1 | Not yet recruiting | National Institute of Neurological Disorders and Stroke (NINDS) | 15 | 2026-11-18 | 2026-11-13 |
| The Study of Brave-LC LDN Treatment Trial naltrexone, Placebo - Post-acute COVID-19 Syndrome | Phase 3 | Not yet recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 1300 | 2026-11-16 | 2026-11-04 |
| Rimonabant for Cognitive Impairment in People With Post-COVID-19 Syndrome Rimonabant, Placebo - Post-COVID-19 Syndrome | Phase 2 | Not yet recruiting | Sinfatin S.L | 80 | 2026-11-06 | 2026-11-12 |
| Fatigue in Long COVID Lightning Process, Activity Pacing - Long COVID | Not applicable | Not yet recruiting | McMaster University | 100 | 2026-11-01 | 2026-07-13 |
| The Precision Mito- Mito Map COMPASS Study Mito Map Energy Score and Home Functional Assessments - Mitochondrial Diseases, Myalgic Encephalomyelitis Chronic Fatigue Syndrome | Not yet recruiting | AI Agent Vault, Inc. d/b/a Precision Mito | 400 | 2026-11-01 | 2026-10-02 | |
| SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID Dysfunction Valacyclovir, Celecoxib, Paxlovid - Post-acute Sequelae of COVID-19, Long COVID | Phase 2 | Recruiting | Icahn School of Medicine at Mount Sinai | 150 | 2026-10-20 | 2026-10-28 |
| Epigenetic Changes in Long COVID Patients Long COVID-19 Syndrome, Long COVID Symptoms | Active not recruiting | Istituti Clinici Scientifici Maugeri SpA | 1000 | 2026-10-12 | 2026-11-04 | |
| Peripheral Nerve Ultrasound in Children With Guillain-Barré Syndrome Guillain-Barre Syndrome | Not yet recruiting | Assiut University | 42 | 2026-10-10 | 2026-10-08 | |
| Whole-body Cryotherapy in Those With Chronic Fatigue: A Feasibility Study Cryotherapy - ME/CFS, Fibromyalgia (FM) | Not applicable | Recruiting | Oxford Brookes University | 40 | 2026-10-05 | 2026-11-05 |
| Post-acute Infectious Syndrome - Aripiprazole Symptom Evaluation (PAIS-AriSE) Aripiprazole (low-dose, 1mg), Placebo - Post-acute Infectious Syndrome (PAIS), Post-COVID-19 Condition (PCC or Long COVID) | Phase 2 | Not yet recruiting | Christiana Franke | 138 | 2026-10-01 | 2026-07-20 |
| Study of VYD2311 for the Treatment of Adults With Long-COVID or Post-Vaccination Syndrome VYD2311, Placebo - Long COVID, COVID-19 (SARS-CoV-2 Infection) | Phase 2 | Not yet recruiting | Invivyd, Inc. | 130 | 2026-10-01 | 2026-10-27 |
| Myocardial Changes in Pediatric Guillain-Barré Syndrome Myocardial Dysfunction, Guillain-Barre Syndrome | Not yet recruiting | Assiut University | 72 | 2026-09-26 | 2026-09-25 | |
| Transcranial Direct Current Stimulation for Long COVID Brain Fog and Fatigue Transcranial Direct Current Stimulation - Long COVID, Post-COVID Conditions | Not applicable | Not yet recruiting | University of Las Palmas de Gran Canaria | 20 | 2026-09-15 | 2026-07-22 |
| Efficacy and Safety of Efgartigimod in the Treatment of Guillain-Barré Syndrome(GREAT) Intravenous immunoglobulin (IVIG), Efgartigimod Alfa-Fcab - Guillain-Barré Syndrome | Phase 2 | Not yet recruiting | Beijing Tiantan Hospital | 110 | 2026-09-01 | 2026-09-18 |
| Five-year Follow-up After Sars-CoV-2 Infection: Prevalence and Evolution of Post-acute Sequalae of COVID-19 (PASC) Post-Acute Sequelae of COVID-19 (PASC) Assessment - Long COVID, COVID-19 | Not yet recruiting | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 900 | 2026-09-01 | 2026-08-14 |
Showing 20 of 747. Sign in to see all of them.
Post-Acute COVID-19 Syndrome (600) · COVID-19 (204) · Guillain-Barre Syndrome (98) · Fatigue (63) · Fatigue Syndrome, Chronic (39) · Motor Activity (29) · Multiple Sclerosis (28) · Mental Fatigue (27) · Cognitive Dysfunction (24) · Post-Lyme Disease Syndrome (22) · Depression (21) · Anxiety Disorders (18) · Dyspnea (18) · Postural Orthostatic Tachycardia Syndrome (17) · Arthritis, Reactive (16)
Disease Attributes (747) · Pathologic Processes (747) · Pathological Conditions, Signs and Symptoms (747) · Chronic Disease (746) · Infections (642) · Respiratory Tract Diseases (605) · Lung Diseases (604) · RNA Virus Infections (603) · Virus Diseases (603) · Coronaviridae Infections (600) · Nidovirales Infections (600) · Pneumonia (600) · Pneumonia, Viral (600) · Respiratory Tract Infections (599)
Exercise (13) · Immunoglobulins, Intravenous (11) · Rehabilitation (9) · Educational Status (8) · Plasmapheresis (8) · Blood Specimen Collection (7) · Acupuncture Therapy (6) · Hyperbaric Oxygenation (6) · Saline Solution (6) · Surveys and Questionnaires (6) · Transcranial Direct Current Stimulation (6) · nirmatrelvir and ritonavir drug combination (6) · Cognitive Training (5) · Physical Therapy Modalities (5) · Magnetic Resonance Spectroscopy (4)
Assiut University (15) · Icahn School of Medicine at Mount Sinai (11) · VA Office of Research and Development (11) · Duke University (9) · Charite University, Berlin, Germany (8) · Columbia University (6) · Johns Hopkins University (6) · Karolinska Institutet (6) · Kanecia Obie Zimmerman (5) · Massachusetts General Hospital (5) · Mayo Clinic (5) · University of Alberta (5) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (4) · Adhera Health, Inc. (4) · Assistance Publique - Hôpitaux de Paris (4)
United States (235) · Spain (55) · Germany (46) · Canada (43) · United Kingdom (35) · Italy (33) · China (28) · France (27) · Brazil (22) · Netherlands (18) · Switzerland (17) · Taiwan (16) · Egypt (15) · Austria (14) · Turkey (Türkiye) (11)
Lucinda Bateman, MD (6) · Brian A Fallon, MD (4) · Avindra Nath, M.D. (3) · Barry Make, MD (3) · Christina Barkauskas, MD (3) · Cyndya Shibao, MD (3) · David Putrino, PT, PhD (3) · Gary M Felker, MD (3) · Janna Friedly, MD, MPH (3) · Kanecia Zimmerman, MD PhD (3) · Pam Taub, MD (3) · Peter Novak, MD (3) · Susan Redline, MD MPH (3)
PMID 41720282, PMID 42282195, PMID 32784198, PMID 33428867, PMID 34273080, PMID 34308300, PMID 39356507, PMID 10377201, PMID 12668799, PMID 12973660, PMID 14715035, PMID 15023839, PMID 16267188, PMID 16271648, PMID 16314677, PMID 16831974, PMID 16849828, PMID 16900450, PMID 17786266, PMID 18258905, PMID 19248087, PMID 19568835, PMID 20155838, PMID 20498207, PMID 20590838, PMID 21622969, PMID 21745374, PMID 21885496, PMID 22003934, PMID 22067635, PMID 22100537, PMID 22168993, PMID 23568718, PMID 23572237, PMID 23875929, PMID 24012996, PMID 24790712, PMID 26320841, PMID 26928074, PMID 27572859, PMID 27694629, PMID 27705091, PMID 27856631, PMID 27993601, PMID 28106111, PMID 28168524, PMID 28406555, PMID 28975040, PMID 29034226, PMID 29128354
2025 (3), OT2HL156812 (3), 2023 (2), 1OT2HL156812 (1), 1OT2HL156812-01 (1), 2019 (1), 272201800011C-P00005-9999-1 (1), 3UM1AI068614-14S1 (1), I01CX002668 (1), I01RX004572 (1), I21RX004092 (1), I21RX004409 (1), K08CA237619 (1), P30AG067988 (1), R01AG085873 (1)